News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News News Equality, diversity and inclusion 27/10/2022 Less women in scientific production, a reality of the COVID-19 lockdown 25/10/2022 Welcome on board the EPIVINF project: the kick-off meeting 16/10/2022 Simultaneous initiation of antiretroviral therapy and immunotherapy leads to better HIV control 09/10/2022 New variant-adapted COVID-19 vaccines: where do we stand? 19/09/2022 An IrsiCaixa project to study Long Covid, one of the 9 Catalan proposals selected by the CaixaResearch call for Health Research 2022 21/07/2022 HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the new subvariants of Omicron 14/07/2022 COVID-19 vaccines: is a second booster necessary at this moment, and for whom? 10/07/2022 Study shows that adding a new antiviral to current COVID-19 treatment could reduce mortality in hospitalised patients by 30% 07/07/2022 Three IrsiCaixa female researchers receive funding from Gilead to keep progressing in the field of HIV and COVID-19 Pagination First Previous Page 1 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Equality, diversity and inclusion 27/10/2022 Less women in scientific production, a reality of the COVID-19 lockdown
16/10/2022 Simultaneous initiation of antiretroviral therapy and immunotherapy leads to better HIV control
19/09/2022 An IrsiCaixa project to study Long Covid, one of the 9 Catalan proposals selected by the CaixaResearch call for Health Research 2022
21/07/2022 HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the new subvariants of Omicron
10/07/2022 Study shows that adding a new antiviral to current COVID-19 treatment could reduce mortality in hospitalised patients by 30%
07/07/2022 Three IrsiCaixa female researchers receive funding from Gilead to keep progressing in the field of HIV and COVID-19